Clinical and ultrasonographic indications for treatment with angiotensin converting enzyme inhibitors after myocardial infarction;Angiotensine-'converting'-enzymremmers na een myocardinfarct: Klinische en echocardiografische indicaties

Nederlands Tijdschrift voor Geneeskunde

Volumn 141, Issue 2, 1997, Pages 84-88

  De Waard, D E P ^a   Kamp, O ^a   Visser, F C ^a   Visser, C A ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LISINOPRIL; RAMIPRIL; TRANDOLAPRIL; ZOFENOPRIL;

DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; HEART FAILURE; HEART INFARCTION; HUMAN; MORTALITY; REVIEW; ULTRASOUND;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ECHOCARDIOGRAPHY; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL INFARCTION; RECURRENCE; VENTRICULAR FUNCTION, LEFT;

EID: 0031013808     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Bindels AJGH, Vandenbroucke JP. Helpen ACE-remmers decompensatio cordis voorkomen? Resultaten van 3 klinische trials. Ned Tijdschr Geneeskd 1993;137:173-6.
2. Hutchins GM, Bulkley BH. Infarct expansion versus extension: two different complications of acute myocardial infarction. Am J Cardiol 1978;41:1127-32.
3. Eaton LW, Weiss JL, Bulkley BH, Garrison JB, Weisfeldt ML. Regional cardiac dilatation after acute myocardial infarction: recognition by two-dimensional echocardiography. N Engl J Med 1979;300:57-62.
4. Weisman HF, Bush DE, Mannisi JA, Weisfeldt ML, Healy B. Cellular mechanisms of myocardial infarct expansion. Circulation 1988;78:186-201.
5. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990;81:1161-72.
6. Anversa P, Olivetti G, Capasso JM. Cellular basis of ventricular remodeling after myocardial infarction. Am J Cardiol 1991;68:70-160.
7. Gaudron P, Eilles C, Kugler I, Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation 1993;87:755-63.
8. Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 1985;57:84-95.
9. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 1985;72:406-12.
10. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive dilatation after anterior myocardial infarction. N Engl J Med 1988;319:80-6.
11. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58.050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-85.
12. Gruppo Italiano per lo Sludio della Sopravvivenza nell'infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994;343:1115-22.
13. Swedberg K, Held P, Kjekhus J, Rasmussen K, Ryden L, Wedel H. Effects of the early administration of enalapril on mortality in patiens with acute myocardial infarction. Results of the Cooperative new Scandinavian enalapril survival study II (CONSENSUS II). N Engl J Med 1992;327:678-84.
14. Ambrosioni E, Borghi C, Magnani B. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-term Evaluation (SMILE) Study Investigators. N Engl J Med 1995;332:80-5.
15. Oral captopril versus placebo among 13.634 patients with suspected acute myocardial infarction: interim report from the Chinese cardiac study (CCS-I). Lancet 1995;345:686-7.
16. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown jr EJ, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992;327:669-77.
17. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821-8.
18. Køber L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dys-function after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 1995;333:1670-6.
19. Tognoni G. ACE inhibitors after myocardial infarction. Lancet 1994;343:1633-4.